These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18788018)

  • 1. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles.
    Bernstein DM; Donaldson K; Decker U; Gaering S; Kunzendorf P; Chevalier J; Holm SE
    Inhal Toxicol; 2008 Sep; 20(11):1009-28. PubMed ID: 18788018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2005 Aug; 17(9):427-49. PubMed ID: 16020039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biopersistence of brazilian chrysotile asbestos following inhalation.
    Bernstein DM; Rogers R; Smith P
    Inhal Toxicol; 2004; 16(11-12):745-61. PubMed ID: 16036745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2003 Dec; 15(14):1387-419. PubMed ID: 14648356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure.
    Bernstein DM; Rogers RA; Sepulveda R; Donaldson K; Schuler D; Gaering S; Kunzendorf P; Chevalier J; Holm SE
    Inhal Toxicol; 2011 Jun; 23(7):372-91. PubMed ID: 21639707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxicological response of Brazilian chrysotile asbestos: a multidose subchronic 90-day inhalation toxicology study with 92-day recovery to assess cellular and pathological response.
    Bernstein DM; Rogers R; Smith P; Chevalier J
    Inhal Toxicol; 2006 May; 18(5):313-32. PubMed ID: 16513591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results.
    Bernstein DM; Rogers RA; Sepulveda R; Donaldson K; Schuler D; Gaering S; Kunzendorf P; Chevalier J; Holm SE
    Inhal Toxicol; 2010 Sep; 22(11):937-62. PubMed ID: 20695727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure.
    Bernstein D; Rogers R; Smith P
    Inhal Toxicol; 2005 Jan; 17(1):1-14. PubMed ID: 15764479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biopersistence of Canadian chrysotile asbestos following inhalation.
    Bernstein DM; Rogers R; Smith P
    Inhal Toxicol; 2003 Nov; 15(13):1247-74. PubMed ID: 14569492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung proliferative and clearance responses to inhaled para-aramid RFP in exposed hamsters and rats: comparisons with chrysotile asbestos fibers.
    Warheit DB; Snajdr SI; Hartsky MA; Frame SR
    Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1219-22. PubMed ID: 9400727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the exposure, dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO
    Bernstein DM; Toth B; Rogers RA; Kling DE; Kunzendorf P; Phillips JI; Ernst H
    Toxicol Appl Pharmacol; 2020 Jan; 387():114856. PubMed ID: 31836523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats.
    Hesterberg TW; Hart GA; Chevalier J; Miiller WC; Hamilton RD; Bauer J; Thevenaz P
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):68-82. PubMed ID: 9875301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the clearance of respirable para-aramid, chrysotile and glass fibres from rat lungs.
    Searl A
    Ann Occup Hyg; 1997 Apr; 41(2):217-33. PubMed ID: 9155241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More on the dynamics of dust generation: the effects of mixing and sanding chrysotile, calcium carbonate, and other components on the characteristics of joint-compound dusts.
    Berman DW; Brorby GP; Sheehan PJ; Bogen KT; Holm SE
    Ann Occup Hyg; 2012 Aug; 56(7):852-67. PubMed ID: 22425655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the deposition, translocation and pathological response of brake dust with and without added chrysotile in comparison to crocidolite asbestos following short-term inhalation: interim results.
    Bernstein DM; Rogers R; Sepulveda R; Kunzendorf P; Bellmann B; Ernst H; Phillips JI
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):28-46. PubMed ID: 24480151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of long, thin chrysotile asbestos fibers in the lungs of rats.
    Coin PG; Roggli VL; Brody AR
    Environ Health Perspect; 1994 Oct; 102 Suppl 5(Suppl 5):197-9. PubMed ID: 7882930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO
    Bernstein DM; Toth B; Rogers RA; Kling DE; Kunzendorf P; Phillips JI; Ernst H
    Toxicol Appl Pharmacol; 2020 Jan; 387():114847. PubMed ID: 31830492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health risk of chrysotile revisited.
    Bernstein D; Dunnigan J; Hesterberg T; Brown R; Velasco JA; Barrera R; Hoskins J; Gibbs A
    Crit Rev Toxicol; 2013 Feb; 43(2):154-83. PubMed ID: 23346982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proliferative and histopathologic changes in rat lungs after inhalation of chrysotile or crocidolite asbestos.
    BéruBé KA; Quinlan TR; Moulton G; Hemenway D; O'Shaughnessy P; Vacek P; Mossman BT
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):67-74. PubMed ID: 8607143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-associated responses to chrysotile.
    Oberdörster G
    Ann Occup Hyg; 1994 Aug; 38(4):601-15, 421-2. PubMed ID: 7978983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.